𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cardiac abnormalities in patients with diffuse malignant pleural mesothelioma

✍ Scribed by Scott Wadler; Dr. Philippe Chahinian; William Slater; Martin Goldman; David Mendelson; James F. Holland


Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
680 KB
Volume
58
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Many patients with diffuse malignant pleural mesothelioma have dyspnea or chest pain. Cardiac symptomatology is frequently difficult to differentiate from symptoms of pleuropulmonary disease. To better define the clinical characteristics of cardiac involvement in patients with mesothelioma, the electrocardiographic (EKG) and echocardiographic findings in 64 patients with biopsy-proven malignant pleural mesothelioma were reviewed. A total of 19/64 (30%) patients had autopsy studies available for review. The EKG was abnormal in 55 patients (89%). Over half (60%) had an arrhythmia, including sinus tachycardia (42%), premature atrial and ventricular contractions (13%), atrial fibrillation (3%), and atrial flutter (1%). Over one thid (37%) had a conduction abnormality, including bundle branch block (13%), hemiblock (8.5%), and incomplete right bundle branch block (13%). Echocardiography revealed a total of 13 patients with pericardial effusions, two with pericardial thickening, and one with an anterior sonolucent space. Of 19 autopsies, cardiac invasion was found in 14 (74%), with more than half to the pericardium and more than one quarter to the myocardium. It is concluded that: (1) clinical cardiac abnormalities occur in the great majority of patients with malignant pleural mesothelioma, (2) pathologic cardiac invasion occurs in the great majority of patients with pleural mesothelioma, and (3) the EKG and echocardiogram are helpful in differentiating cardiac involvement from progressive pulmonary disease in patients with pleural mesothelioma.


πŸ“œ SIMILAR VOLUMES


Thrombocytosis in patients with malignan
✍ Line Lisbeth Olesen; Henning Thorshauge πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 229 KB πŸ‘ 2 views

Platelet counts were studied retrospectively in a series of 64 patients suspected of primary malignant pleural mesothelioma. Only platelet counts taken before chemotherapy and radiotherapy and surgery other than thoracocentesis were considered. Thirty-two patients had malignant pleural mesothelioma

Gemcitabine and vinorelbine in pemetrexe
✍ Paolo A. Zucali; Giovanni L. Ceresoli; Isabella Garassino; Fabio De Vincenzo; Ra πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

## Abstract ## BACKGROUND Pemetrexed‐cisplatin chemotherapy is the standard of care in the first‐line treatment of unresectable malignant pleural mesothelioma (MPM). Second‐line cytotoxic therapy is considered for a growing group of patients, but the optimal treatment has not been defined to date.